Delivra Health | DreamWater | LivRelief
Delivra Health Brands logo
toggle menu

0.04 - 0.01

Harvest One Announces the Postponement of Filing Interim Financial Statements and Management's Discussion and Analysis Due to COVID-19

May 25, 2020 – Vancouver, British Columbia – Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSX-V: HVT; OTCQX: HRVOF) announces the postponement of filing its interim consolidated financial statements, accompanying management’s discussion and analysis and related CEO and CFO certifications for the three and nine months ended March 31, 2020 (the "Interim Filings"), due to logistical delays and circumstances caused by the COVID-19 pandemic.  The Company is relying on the British Columbia Securities Commission’s BC Instrument 51-515 – Temporary Exemption from Certain Corporate Finance Requirements (the "Blanket Order").

Under the Blanket Order, a person or company required to make certain filings during the period from March 23, 2020 to June 1, 2020, as described in the Blanket Order, is provided with an additional 45 days from the deadline otherwise applicable under National Instrument 51-102 – Continuous Disclosure Requirements ("NI 51-102") to make such filings. Pursuant to the Blanket Order, the Company is relying on the relief therein for the filing of its Interim Filings as required by subsections 4.4(b) and 5.1(2) of NI 51-102 and section 5.1 of National Instrument 52-109 – Certification of Disclosure in Issuer’s Annual and Interim Filings ("NI 52-109") .

Until the Company has filed the required Interim Filings, all management and other insiders are subject to the Company's share trading and black-out policy that reflects the principles in section 9 of National Policy 11-207 – Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.

Harvest One is continuing to work diligently and expeditiously to prepare and finalize its Interim Filings. The Company estimates that the Interim Filings required under NI 51-102 and NI 52-109 will be filed by June 30, 2020. The Company confirms that since the filing of its last interim consolidated financial statements on March 2, 2020, there have been no material business developments required to be reported by the Company under applicable securities laws and stock exchange requirements, other than those that have already been publicly disclosed.

About Harvest One

Harvest One is a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world. The Company's range of lifestyle solutions is designed to enhance quality of life. Shareholders have significant exposure to a broad cannabis value chain through its wholly-owned subsidiaries: United Greeneries, a Licensed Producer; Satipharm (medical and nutraceutical); and Dream Water Global, and Delivra (consumer); as well as a controlling interest in Greenbelt Greenhouse. For more information, please visit

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance about Harvest One and its business and operations, which include, among other things, statements relating to the expected timing of filing the Interim Filings. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The forward-looking information contained in this press release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more Information:

Investor Relations:
Colin Clancy   
Investor Relations

Media and Other Enquiries:
Nicholas Van Dyk
Vincic Advisors

Email Signup